Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan.

about

New-Generation Coronary Stents: Current Data and Future Directions.Bioresorbable Polymers and Stent Devices.Innovative interventional catheterization techniques for congenital heart disease.

P2860

Q31164040-EFCC7E8E-0232-420C-9F51-B927F9A376E9 Q38919254-3B50C195-1381-4B69-8031-F8A4B429521B Q54941385-6C0D5C6D-2DC4-472F-9DAD-97DA9054BA71

P2860

Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan.

Item

http://www.wikidata.org/entity/Q38472279

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bioresorbable polymeric scaffo ...... BSORB China, and ABSORB Japan.

@en

type

Item

label

Bioresorbable polymeric scaffo ...... BSORB China, and ABSORB Japan.

@en

prefLabel

Bioresorbable polymeric scaffo ...... BSORB China, and ABSORB Japan.

@en

P1476

Bioresorbable polymeric scaffo ...... BSORB China, and ABSORB Japan.

@en

P2093

Bill D Gogas

http://www.w3.org/2001/XMLSchema#string

Habib Samady

http://www.w3.org/2001/XMLSchema#string

Spencer B King

http://www.w3.org/2001/XMLSchema#string

P2860

Bioresorbable scaffolds for percutaneous coronary interventions

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Novel drug-eluting stents for coronary revascularization.

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.

Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

Treatment of coronary artery disease from the inside: Light at the end of the tunnel?

Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial.

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5339/GCSP.2015.62

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26925407

http://www.w3.org/2001/XMLSchema#string

P921

revascularization

P932

4754558

http://www.w3.org/2001/XMLSchema#string

Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan.

about

P2860

P2860

Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932